PATIENTS SUFFERING from breast cancer might take it hard, but it has emerged in a new lab trial that the highly awaited Roche drug Avastin does very little in order to help patients suffering from breast cancer. Reports say that the U. S. Food and Drug Administration (FDA) has plans of taking the drug off the shelfs in the market.
For scores of breast cancer affected patients, Avastin was a highly awaited drug that could enable them to take on their fight against breast cancer although trials which were conducted earlier showed that the drug merely helps in reducing the size of the tumour that grows with breast cancer. Other main reason to conduct this test was to analyze whether does this drug can take an affective stand against the people suffering from it in the longer run or does it just help in reducing the size of the tumour.
The anticipation and thoughts of finally coming across a sustainable solution back fired when the FDA decided to take remove the drug so as to avoid further complications.
Read More >> Breast Cancer , Health Care Tips
No comments:
Post a Comment